Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

121 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Neoadjuvant Cabozantinib and Nivolumab Converts Locally Advanced HCC into Resectable Disease with Enhanced Antitumor Immunity.
Ho WJ, Zhu Q, Durham J, Popovic A, Xavier S, Leatherman J, Mohan A, Mo G, Zhang S, Gross N, Charmsaz S, Lin D, Quong D, Wilt B, Kamel IR, Weiss M, Philosophe B, Burkhart R, Burns WR, Shubert C, Ejaz A, He J, Deshpande A, Danilova L, Stein-O'Brien G, Sugar EA, Laheru DA, Anders RA, Fertig EJ, Jaffee EM, Yarchoan M. Ho WJ, et al. Among authors: philosophe b. Nat Cancer. 2021 Sep;2(9):891-903. doi: 10.1038/s43018-021-00234-4. Epub 2021 Jul 29. Nat Cancer. 2021. PMID: 34796337 Free PMC article. Clinical Trial.
Sarcopenia adversely impacts postoperative complications following resection or transplantation in patients with primary liver tumors.
Valero V 3rd, Amini N, Spolverato G, Weiss MJ, Hirose K, Dagher NN, Wolfgang CL, Cameron AA, Philosophe B, Kamel IR, Pawlik TM. Valero V 3rd, et al. Among authors: philosophe b. J Gastrointest Surg. 2015 Feb;19(2):272-81. doi: 10.1007/s11605-014-2680-4. Epub 2014 Nov 12. J Gastrointest Surg. 2015. PMID: 25389056 Free PMC article.
Accuracy of Milan, University of California San Francisco, and Up-To-7 Criteria in Predicting Tumor Recurrence Following Deceased-Donor Liver Transplant in Patients With Hepatocellular Carcinoma.
Saberi B, Garonzik-Wang J, Ma M, Ajayi T, Kim A, Luu H, Jakhete N, Pustavoitau A, Anders RA, Georgiades C, Kamel I, Ottmann S, Philosophe B, Cameron AM, Gurakar A. Saberi B, et al. Among authors: philosophe b. Exp Clin Transplant. 2020 Aug;18(4):463-469. doi: 10.6002/ect.2017.0288. Epub 2018 Aug 6. Exp Clin Transplant. 2020. PMID: 30084757 Free PMC article.
Detection of Novel Fusion Transcript VTI1A-CFAP46 in Hepatocellular Carcinoma.
Tsuge S, Saberi B, Cheng Y, Wang Z, Kim A, Luu H, Abraham JM, Ybanez MD, Hamilton JP, Selaru FM, Villacorta-Martin C, Schlesinger F, Philosophe B, Cameron AM, Zhu Q, Anders R, Gurakar A, Meltzer SJ. Tsuge S, et al. Among authors: philosophe b. Gastrointest Tumors. 2019 Aug;6(1-2):11-27. doi: 10.1159/000496795. Epub 2019 Apr 10. Gastrointest Tumors. 2019. PMID: 31602373 Free PMC article.
Protein synthesis inhibitor omacetaxine is effective against hepatocellular carcinoma.
Li L, Halpert G, Lerner MG, Hu H, Dimitrion P, Weiss MJ, He J, Philosophe B, Burkhart R, Burns WR, Wesson RN, MacGregor Cameron A, Wolfgang CL, Georgiades C, Kawamoto S, Azad NS, Yarchoan M, Meltzer SJ, Oshima K, Ensign LM, Bader JS, Selaru FM. Li L, et al. Among authors: philosophe b. JCI Insight. 2021 Jun 22;6(12):e138197. doi: 10.1172/jci.insight.138197. JCI Insight. 2021. PMID: 34003798 Free PMC article.
121 results